Quest Diagnostics Inc
NYSE:DGX

Watchlist Manager
Quest Diagnostics Inc Logo
Quest Diagnostics Inc
NYSE:DGX
Watchlist
Price: 183.65 USD -0.29%
Market Cap: 20.4B USD

Quest Diagnostics Inc
Interest Expense

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Quest Diagnostics Inc
Interest Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Expense CAGR 3Y CAGR 5Y CAGR 10Y
Quest Diagnostics Inc
NYSE:DGX
Interest Expense
$282m
CAGR 3-Years
23%
CAGR 5-Years
11%
CAGR 10-Years
6%
CVS Health Corp
NYSE:CVS
Interest Expense
$3.1B
CAGR 3-Years
10%
CAGR 5-Years
1%
CAGR 10-Years
16%
Cigna Corp
NYSE:CI
Interest Expense
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Hims & Hers Health Inc
NYSE:HIMS
Interest Expense
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Laboratory Corporation of America Holdings
NYSE:LH
Interest Expense
$232.5m
CAGR 3-Years
10%
CAGR 5-Years
1%
CAGR 10-Years
-1%
Guardant Health Inc
NASDAQ:GH
Interest Expense
$3.4m
CAGR 3-Years
9%
CAGR 5-Years
57%
CAGR 10-Years
N/A
No Stocks Found

Quest Diagnostics Inc
Glance View

In the rapidly evolving world of healthcare, Quest Diagnostics Inc. stands as a pivotal player, shaping the future of diagnostic services. Born out of a quest for innovation in clinical testing, Quest Diagnostics operates at the intersection of medical science and cutting-edge technology. The company has a wide-reaching network of laboratories and service centers, offering a comprehensive array of diagnostic testing solutions that range from routine blood tests to advanced genetic screening. Their services are not limited to hospitals and physician offices; they extend into a variety of sectors including pharmaceuticals, food, and global business services, completing over a hundred million clinical laboratory tests annually. Quest's robust infrastructure and commitment to precision ensure that patients and healthcare providers receive timely and accurate information that is crucial for early detection, diagnosis, and informed treatment decisions. Quest Diagnostics' revenue model is straightforward yet effective, driven primarily by service fees from its expansive menu of tests. By collaborating with insurers, healthcare providers, and employers, Quest ensures broad access to its services. Moreover, the company continually invests in research and development to expand its test portfolio and enhance the quality of its services, thus staying competitive in the fast-paced healthcare environment. Through strategic acquisitions and partnerships, Quest has broadened its geographical reach and bolstered its technological capabilities, maintaining its position as an industry leader. As healthcare increasingly leans toward personalized medicine and preventive care, Quest Diagnostics is poised to leverage its analytical prowess and deep repository of health data to drive future growth and innovation, serving as an indispensable ally in global public health.

DGX Intrinsic Value
190.48 USD
Undervaluation 4%
Intrinsic Value
Price

See Also

What is Quest Diagnostics Inc's Interest Expense?
Interest Expense
282m USD

Based on the financial report for Sep 30, 2025, Quest Diagnostics Inc's Interest Expense amounts to 282m USD.

What is Quest Diagnostics Inc's Interest Expense growth rate?
Interest Expense CAGR 10Y
6%

Over the last year, the Interest Expense growth was 41%. The average annual Interest Expense growth rates for Quest Diagnostics Inc have been 23% over the past three years , 11% over the past five years , and 6% over the past ten years .

Back to Top